Home > News content

Global donation of 7.4 billion euros to support the development of new coronavirus vaccine

via:驱动之家     time:2020/5/5 9:30:36     readed:465

On May 4 local time, under the organization of the European Union, more than 40 countries around the world gathered to discuss how to deal with the new covid-19 coronavirus,For this reason, 7.4 billion euros (about 57 billion yuan) has been donated by various countries for the research and development of new coronavirus vaccine, diagnosis and treatment And WHO director-general of the World Health Organization, Tantesse, says vaccines should be distributed equitably around the world.

Vaccine is the most effective way to control the future transmission of new coronavirus. At present, all countries are actively developing vaccines. At this conference, more than 40 countries committed 7.4 billion euros, which will undoubtedly greatly promote the development of covid-19 vaccine and other treatment and diagnosis technologies.

Because of the different levels of development in each country, the application of vaccines will be different, and developed countries tend to have an advantage in this regard, WHO initiatives initiated initiatives with countries to treat vaccines equally. Tantesse says countries are committed not only to accelerating vaccine development but also to equitable distribution.

The criteria for success, says Mr Tantesse, are not just how quickly you can develop safe and effective tools, but how you distribute them fairly.

At the beginning of this month, the development of new coronavirus vaccine was announced on the official website of who. At present, 8 vaccines in the world have entered the clinical stage,China 's R & D accounted forFour of them, three of them are inactivated vaccines, the other one is adenovirus vector vaccine, that is, the new vaccine being developed by academician Chen Wei's team, has entered the clinical phase II study.

Of the four other vaccines, the U.S. has developed three, the main technical route is the RNA vaccine, the DNA vaccine, and one is the British University of Oxford developed a non-replicated AD vector vaccine.


China IT News APP

Download China IT News APP

Please rate this news

The average score will be displayed after you score.

Post comment

Do not see clearly? Click for a new code.

User comments